The diagnosis of CLL is easy in the presence of characteristic immunophenotypic features (CD5+CD19+ dual-positive, CD23+, CD22-/low, CD79b-/low, sIg low, FMC7-, and CD20 low). This evidence concerns the gene CD22 and B-cell chronic lymphocytic leukemia.